Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Defining the Genetic Etiology of Suppurative Lung Disease in Children and Adults

NCT04702243 is registered in ClinicalTrials.gov with University of North Carolina, Chapel Hill as lead sponsor.

NCT NCT04702243
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04702243 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Defining the Genetic Etiology of Suppurative Lung Disease in Children and Adults
Lead sponsor
University of North Carolina, Chapel Hill
Phase
Observational
Overall status
Completed
Start date
December 1, 2020
Completion date
August 6, 2025
Enrollment
436 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

kartagener syndrome, primary ciliary dyskinesia, primary immune deficiency